Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179022-17-000080
Filing Date
2017-12-18
Accepted
2017-12-18 16:13:12
Documents
1
Period of Report
2017-12-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3742
  Complete submission text file 0001179022-17-000080.txt   5239
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5835 STRASBOURG COURT --- RENO NV 89511
Business Address
AMELIO GILBERT F (Reporting) CIK: 0001183247 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 171261523